Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and technologies that improve patient outcomes. Editor’s Note: This is part three ...
This important study employs a closed-loop, theta-phase-specific optogenetic manipulation of medial septal parvalbumin-expressing neurons in rats and reports that disrupting theta-timescale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback